China Cord Blood Corporation to Announce Third Quarter Fiscal 2011 Financial Results
HONG KONG, Feb. 22, 2011 /PRNewswire-Asia-FirstCall/ — China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”) today announced its plan to release financial results for the third quarter and first nine months of fiscal year 2011 on Monday, February 28, 2011, after market close in the US.
The Company will hold a teleconference at 8:00 p.m. ET on Monday, February 28, 2011 to discuss its financial performance and give a brief overview of the Company’s recent developments, followed by a question and answer session. Interested parties may access the audio webcast through the following link: http://investor.chinacordbloodcorp.com/playerlink.zhtml?c=206671&s=wm&e=3696924. A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above. Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or +852-2475-0994 for Hong Kong callers, access code: 40003001.
Supplemental financial information referenced in the conference call and the text of the third quarter press release will be available at http://www.chinacordbloodcorp.com, in the section titled Investor Center/Press Release, after 4:30 p.m. ET on the day of the conference call.
Please dial in ten minutes prior to the conference to ensure proper connection and be prepared to provide your name and company to the operator.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.
For more information, please contact: China Cord Blood Corporation Ms. Joeling Law Tel: +852-3605-8180 Email: email@example.com ICR, LLC In New York: Ashley M. Ammon Tel: +1-646-277-1227 In Beijing: Wen Lei Zheng Tel: +86-10-6583-7510
SOURCE China Cord Blood Corporation